Tributyrin (Butyrate Prodrug).

Tributyrin is glycerol esterified with three butyrate molecules, released by lipases in the small intestine. It delivers the same short-chain fatty acid without the odour and rapid loss of the free acid.

Butyrate stays bound in the triglyceride until lipase cleaves the ester bonds. Pancreatic or supplemental lipase is what converts the prodrug into the active acid.

Colonic bacteria ferment resistant starch preferentially to butyrate in the distal gut, while tributyrin delivers butyrate proximally. The two cover different lengths of the tract.

Inulin fermentation yields short-chain fatty acids including butyrate through cross-feeding between bacterial groups. Tributyrin supplies butyrate directly while inulin builds the microbial capacity to make it.

Partially hydrolysed guar ferments slowly and steadily along the colon, raising butyrate output. It complements the proximal delivery tributyrin gives.

F. prausnitzii is one of the dominant butyrate-forming species in the human colon. Supplying butyrate directly and supporting the organism that makes it address the same colonocyte fuel.

Akkermansia degrades mucin into acetate and propionate that butyrate-producing species use as substrate. It raises butyrate output indirectly through that cross-feed.

Glutamine is the preferred fuel of small intestinal enterocytes while butyrate is the preferred fuel of colonocytes. The two supply energy to different segments of the same lining.

GOS is fermented largely by bifidobacteria to acetate and lactate, which butyrate producers convert onward. The chain ends at the same short-chain fatty acid.

Zinc carnosine adheres to the mucosal surface and supports tight junction proteins, while butyrate supplies the energy epithelial cells use to maintain that barrier.

Tributyrin is a triglyceride and has to be hydrolysed before any butyrate is released. Pancreatic and gastric lipases cleave the ester bonds, yielding free butyric acid plus mono- and dibutyrin. Where lipase output is low, less of an oral dose is converted, which makes the enzyme step the rate-limiting one rather than a bonus.

Bile salts emulsify dietary triglycerides into micelles, which is what gives lipase access to the ester bonds. Tributyrin is a short-chain triglyceride and is handled more readily than long-chain fats, but the same emulsification step still governs how efficiently it is cleaved. This is standard digestive physiology, not a combination trial finding.

Medium-chain triglycerides are commonly used as the carrier oil in tributyrin softgels because the two are miscible and share a hydrolysis route. That shared route means they draw on the same lipase capacity, so a large simultaneous fat load can slow the release of either. The pairing is mostly a vehicle decision.

Psyllium is partially fermented in the colon by resident bacteria, and butyrate is one of the short-chain fatty acids produced. Oral tributyrin delivers butyrate directly rather than by fermentation, so the two arrive at overlapping endpoints from different directions. Combining them raises butyrate supply from both a substrate route and a direct route.

Pectin is a readily fermentable soluble fibre and a recognised substrate for short-chain fatty acid production by colonic bacteria. Pairing it with tributyrin combines a fermentation-derived butyrate supply with a directly delivered one. How much butyrate any individual produces from pectin depends on their own microbial community.

Oat beta-glucan is a viscous, fermentable polysaccharide that colonic bacteria convert to acetate, propionate and butyrate. Tributyrin bypasses that conversion entirely. The two are complementary rather than duplicative, since fermentation output varies with the microbial community present.

Guar galactomannan is fermented in the proximal colon and is one of the more reliably butyrogenic fibres. Alongside tributyrin it contributes butyrate through the microbial route while the triglyceride contributes it through hydrolysis. Neither route substitutes for the other.

Konjac glucomannan is a viscous fibre that reaches the colon largely intact and is fermented there to short-chain fatty acids. The butyrate share of that output varies considerably between individuals. Tributyrin provides a route that does not depend on that variability.

Fructooligosaccharides are fermented mainly by bifidobacteria, which produce lactate and acetate rather than butyrate directly. Butyrate-producing species then cross-feed on those products, which is how a bifidogenic fibre raises butyrate indirectly. Tributyrin adds butyrate without needing that two-step chain to be intact.

Bifidobacteria ferment carbohydrate to acetate and lactate, the substrates that butyrate-producing species such as Faecalibacterium and Eubacterium use. That cross-feeding chain is the main way a probiotic raises colonic butyrate. Pairing with tributyrin covers both the microbial route and the direct one.

Lactobacilli generate lactate, which butyrate-producing species convert onward through the lactate-utilising pathway. The size of that conversion depends on which butyrate producers a person carries. It is a plausible complement to a directly delivered butyrate source rather than a duplicate of it.

This yeast does not produce butyrate itself but is described as shifting the bacterial community in ways that alter short-chain fatty acid output. The pairing rationale is community-level rather than a direct biochemical hand-off. Confidence stays at the lowest band because the effect on butyrate specifically is not established.

Bovine colostrum supplies immunoglobulins and growth factors that act at the intestinal surface, while butyrate is the preferred oxidative fuel of colonocytes. The two converge on epithelial function from different directions. No study in the candidate set tests them together, so this stays a mechanistic pairing.

Lactoferrin binds iron at the mucosal surface and shifts the competitive balance between microbial species, which indirectly affects fermentation output. Tributyrin acts downstream of any such shift by delivering butyrate directly. The connection is indirect and is labelled as such.

Divalent calcium forms insoluble soaps with free fatty acids released during lipid digestion, which is why high calcium loads reduce measured fat absorption. Butyric acid liberated from tributyrin in the small intestine is subject to the same chemistry, although short-chain soaps are far more soluble than long-chain ones. The effect is worth flagging in a formulation that pairs a large calcium dose with a lipid-delivered active.

Activated charcoal adsorbs organic molecules non-selectively across a very large surface area and does not distinguish an intended active from anything else in the gut lumen. Taken at the same time as tributyrin it can reduce how much reaches its site of hydrolysis. Separating the doses in time is the usual formulation response.

Bentonite is a layered aluminosilicate that binds cations and polar organics in the gut lumen. Its binding is less avid than activated charcoal but the same timing caution applies to a co-administered lipid active. This is adsorption chemistry rather than a documented interaction study.

Long-chain omega-3 triglycerides and tributyrin are both lipase substrates, so a large combined fat dose spreads the same enzyme capacity across more substrate. In practice short-chain triglycerides are cleaved quickly and this matters mainly at high combined doses. Read it as a formulation consideration rather than a clinical interaction.